The Panomics division of Affymetrix has extensively supported researchers throughout all of the various phases of the drug discovery and development process. With our extensive and expansive portfolio of our QuantiGene and Procarta assays, we have been able to aid our customers with the efficiency, performance and accuracy of their assays in areas such as assay development, high-throughput screening, metabolic and safety assessment, target validation and clinical trials.
This information provided here is designed to show the following:
